tetracyclines
Recent Rosacea Blog Posts
In a crowded rosacea topical market, Hovione is trialing a new topical antibiotic formulation – 1% vs. 3% minocycline gel. HY01 is said to be based on a “proprietary formulation of crystalline minocycline base and oil-based excipients.” In the topical anti-papule and pustule market, this new formulation of Minocycline is up against the industry heavyweights […]
I don’t know if rosacea sufferers really need another tetracycline variant, but Allergan has published some promising Phase III trial data for Sarecycline as a treatment for the lesions of moderate to severe acne. Whilst no longer being directly promoted as a treatment for rosacea (and indeed it is not clear if Allergan will be […]
The New York Times is reporting on the health status of the President, based on an interview with his doctor – Harold N. Bornstein. The interview includes mention that Trump is taking a long acting tetracycline to control his rosacea. It isn’t clear which formulation of tetracycline this would refer to. I’m sure the reporting is […]
Proving once again that you shouldn’t rely on the mainstream media for your health news, blanket coverage today for a Danish statistical population study that uses the words Rosacea and Parkinson’s in the title. Even simply using the two words in the same headline implies some kind of link – reading the details of the […]
Promius Pharma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for seborrheic […]
